Renal Cancer - Results from #5660

Percutaneous radiofrequency ablation of renal tumors in high-risk patients: 10 years' experience June 13, 2016

Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data June 10, 2016

Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors June 10, 2016

Prescribing Preferences in the First-Line Treatment for Patients With Metastatic Renal Cell Carcinoma in the United States June 10, 2016

Genetic scores based on risk-associated single nucleotide polymorphisms (SNPs) can reveal inherited risk of renal cell carcinoma June 9, 2016

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma June 9, 2016

[ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies] June 8, 2016

Differences in Overall and Cancer-Specific-Survival of Patients Presenting with Chromophobe Vs. Clear Cell Renal Cell Carcinoma: A Propensity Score Matched Analysis June 7, 2016

Design and Reporting of Targeted Anti-Cancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy June 7, 2016

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas June 7, 2016

Biomarkers for Wilms Tumor: a Systematic Review June 7, 2016

Novel imaging in renal cell carcinoma June 6, 2016

Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Versus Malignant Disease and Low- Versus High-Risk Renal Tumors June 6, 2016

Update on active surveillance for clinical T1 renal tumors June 5, 2016

Lymph node dissection for renal cell carcinoma: what are we missing? June 5, 2016

Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population June 1, 2016

Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma May 31, 2016

Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study May 31, 2016

Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan May 31, 2016

Papillary Renal-Cell Carcinoma May 30, 2016

Page 284 of 456